John B. Moriarty

Insider Reports History

Location
San Diego, CA
Signature
/s/ Michael F. MacLean, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by John B. Moriarty:

Company Role Class Num Shares Value Price $ Report Date Ownership
Avidity Biosciences, Inc. Chief Legal Officer Common Stock 74,557 $5,385,252 $72.23 07 Jan 2026 Direct
Olema Pharmaceuticals, Inc. EVP, Ch. Legal Officer & Sec. Stock Option (Right to Buy) 150,000 01 Feb 2023 Direct
Mirati Therapeutics, Inc. Chief Legal Officer Common Stock 0 $59.02 23 Jan 2024 Direct
Mirati Therapeutics, Inc. Chief Legal Officer Option to Purchase Common Stock 0 23 Jan 2024 Direct

Insider Reports Filed by John B. Moriarty

Symbol Company Period Transactions Value $ Form Type Role Filing Time
RNA Avidity Biosciences, Inc. 07 Jan 2026 1 -$171,474 4 Chief Legal Officer 09 Jan 2026, 17:12
RNA Avidity Biosciences, Inc. 17 Dec 2025 2 -$1,927,841 4 Chief Legal Officer 19 Dec 2025, 08:26
RNA Avidity Biosciences, Inc. 04 Aug 2025 1 -$81,291 4 Chief Legal Officer 05 Aug 2025, 17:27
RNA Avidity Biosciences, Inc. 06 Jan 2025 2 $0 4 Chief Legal Officer 08 Jan 2025, 20:29
RNA Avidity Biosciences, Inc. 01 Aug 2024 2 $0 4 Chief Legal Officer 05 Aug 2024, 09:11
RNA Avidity Biosciences, Inc. 01 Aug 2024 0 $0 3 Chief Legal Officer 05 Aug 2024, 09:06
/report/000114036124003540-moriarty-john-b-2024-01-23 Mirati Therapeutics, Inc. 23 Jan 2024 3 $0 4 Chief Legal Officer 23 Jan 2024, 20:37
/report/000162828023028878-moriarty-john-b-2023-08-09 Mirati Therapeutics, Inc. 09 Aug 2023 1 +$824,989 4 Chief Legal Officer 10 Aug 2023, 16:22
/report/000162828023023348-moriarty-john-b-2023-06-23 Mirati Therapeutics, Inc. 23 Jun 2023 0 $0 3 Chief Legal Officer 23 Jun 2023, 17:15
OLMA Olema Pharmaceuticals, Inc. 01 Feb 2023 1 $0 4 EVP, Ch. Legal Officer & Sec. 02 Feb 2023, 16:34
OLMA Olema Pharmaceuticals, Inc. 01 Feb 2022 1 $0 4 EVP, CH. LEGAL OFFICER & SEC. 03 Feb 2022, 18:05